The Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)
Pune, India -- (SBWIRE) -- 06/14/2018 -- "Global Hemostats Market" is expected to reach USD 4.5 billion by 2024 from USD 2.7 billion in 2016, growing at a CAGR of 6.6% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Thrombin based hemostats market has the largest market segment in hemostats market.
Request for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-hemostats-market
The Global Hemostats Market is highly concentrated market with major key players and local players to cater the domestic market. Ethicon US LLC dominated the hemostats market accounting for the highest market share in 2016, followed by Pfizer Inc., and C.R. Bard Inc. Other players in the market include Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch Therapeutics Inc., Biom'Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., Hemostasis, LLC, MedTrade Products Limited., Integra LifeSciences Corporation, Medline Industries, Inc., HEMOTEC MEDICAL GMBH, Stryker, CSL Behring, Mallinckrodt, and Equimedical, B.V. holds a share of 15.3% of the global hemostats market in 2016.
ETHICON US, LLC (SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC):
Founded in 1886 and headquartered at New Brunswick, New Jersey, U.S., Ethicon US, LLC., a subsidiary of Johnson & Johnson Services, Inc. is engaged in the development and marketing of healthcare products. The company operates through three business segments- Consumer, Pharmaceutical, and Medical Devices.
Recent developments:
1. In June, 2017 Ethicon US, LLC received FDA approval for SURGICEL powder absorbable hemostats. This hemostats powder will help surgeons to have a simple and predictable adjunctive hemostatic solution to control continuous oozing on broad or raw surfaces.
2. In August, 2016 Ethicon US, LLC collaborated with Touch Surgery to improve patient's condition through Ethicon surgical products.
Inquiry Before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hemostats-market
Pfizer:
Founded in 1849 and headquartered in New York, U.S., Pfizer Inc., is engaged in discovering, developing and, manufacturing of healthcare products. Pfizer operates through two segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment concentrates on creating and commercializing immunizations and prescriptions that enhance patients' lives, and in addition products for the end user health care. The EH segment includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems, inadditon to research and development.
View Full Report Visit @ http://databridgemarketresearch.com/reports/global-hemostats-market/
C.R BARD:
Founded in 1907 and headquartered at Murray Hill, New Jersey, USA, C. R. Bard, Inc. is engaged in the development, manufacturing and marketing of medical technologies. The company operates through four business segments- vascular, urology, oncology, and surgical specialties.
Recent Developments:
1. In August, 2013 C. R. Bard, Inc. acquired Medafor, Inc. a leading developer and supplier of plant based hemostatic agents. This acquisition would enhance the company's business opportunities.
Segmentation of Global Hemostats Market:
The Global Hemostats Market is segmented on the basis of type, application, distribution channel, and end user.
The global hemostats market is segmented into 5 major types, namely
- Thrombin Based Hemostats
- Combination Agents
- Oxidized Regenerated Cellulose Based Hemostats
- Gelatin Based Hemostats
- Collagen Based Hemostats
In 2017, the thrombin based hemostats segment is expected to dominate the market with a share of ~38.0% and collagen agents is expected to grow with the highest CAGR during the forecast period from 2017 to 2024.
On the basis of application, the market is segmented into:
- Surgery
- Wound Closure
On the basis of end users, the market is classified into:
- Hospitals
- Community Healthcare
- Ambulatory Centres
- Clinics
In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.
Speak to Experts Visit @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-hemostats-market
Table of Contents:
1. INTRODUCTION
2. MARKET SEGMENTATION
3. MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES
4. PREMIUM INSIGHTS
5. REGULATORY
6. REIMBURSEMENT
7. EXECUTIVE SUMMARY
8. GLOBAL HEMOSTATS MARKET, BY TYPE
9. GLOBAL HEMOSTATS MARKET,BY APPLICATION
10. GLOBAL HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL
11. GLOBAL HEMOSTATS MARKET, BY END USER
12. GLOBAL HEMOSTATS MARKET, BY GEOGRAPHY
12.1. OVERVIEW
12.2. NORTH AMERICA
12.3. EUROPE
12.4. ASIA-PACIFIC (APAC)
12.5. SOUTH AMERICA
12.6. MEA
13. GLOBAL HEMOSTATS MARKET, COMPANY LANDSCAPE
14. COMPANY PROFILES
14.1. ETHICON US, LLC (SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC)
14.2. PFIZER
14.3. C.R BARD
14.4. BAXTER
14.5. VASCULAR SOLUTIONS, INC (ACQUIRED BY TELEFLEX INCORPORATED)
14.6. B.BRAUN MELSUNGEN AG
14.7. 3-D MATRIX LTD
14.8. RESORBA MEDICAL GMBH
14.9. ANIKA THERAPEUTICS, INC.
14.10. BIOM'UP
14.11. CRYOLIFE, INC.
14.12. EQUIMEDICAL
14.13. HEMOSTASIS, LLC
14.14. MEDTRADE PRODUCTS LIMITED
14.15. STRYKER
14.16. ARCH THERAPEUTICS, INC.
14.17. INTEGRA LIFESCIENCES CORPORATION
14.18. ALTAYLAR MEDICAL
14.19. BIOCER ENTWICKLUNGS-GMBH
14.20. SMI (STARCH MEDICAL)
About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com